Market Research Logo

Global Advanced Visualization Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Advanced Visualization Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

The global advanced visualization market is expected to grow with the CAGR of approximately 11.4% during the forecast period. Technological advancement is one of the major factors boosting the market demand. Advanced visualization has come a big way since its initiates like a tool for dedicated studies such as CT colonography (CTC) and cardiac CT. Today, decentralization of visualization software from a thick client to a thin client combined with the procuring of tools on advanced visualization (AV), PACS workstations is playing highly essential role in medical imaging. Such trend toward using AV applications from a centralized server is now more vital as many radiologists constantly to report remotely. More factors such as growing use of advanced visualization technique in hospitals, growing focus of healthcare organizations to increase workflow efficiency and prevalence of cancer and CVD across the globe are also supporting to boost the market demand across the globe. However, technical complexities and high cost of AV tools are some factors hindering the market growth. The market has huge scope with the growing medical tourism across the globe and increasing healthcare expenditure in developing countries. The market is facing some challenges such as high initial investment and lack of skilled professionals. Geographically, North America is the leader in the market due to growing healthcare infrastructure coupled with high healthcare spending in the region. Moreover, growing prevalence of Cancer in the region is also boosting the demand for advanced diagnostic solutions in the region. Asia Pacific is also expected to witness potential growth in near future with the growing demand for advanced visualization solutions in China & India coupled with growing medical tourism in the region. Moreover, the presence of major players such as GE healthcare, Carestream Health, Philips, Siemens AG, Vital images etc. are offering better opportunity for more innovations.

The global advanced visualization market has been categorized on the basis of type of platform, application and end user. According to type of platform, the market is further segmented into computed tomography, ultrasound, positron emission tomography (PET), Radiotherapy (RT), Magnetic resonance imaging (MRI) and others. Among type of platform, CT (computed tomography) was accounted for major share owing to high popularity of such imaging test in diagnostic centers. According to application, the market is further segmented into neurology, oncology, cardiology, orthopedics and other applications. Oncology is one of the major application segments owing to rapid growth in cancer cases globally. According to end user, the market is further segmented into academic & research centers, imaging centers, hospitals & surgical centers and other end users. Hospitals & surgical centers are one of the major users of such systems for accurate and precise images which supports for better interpretation of results.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL ADVANCED VISUALIZATION MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360 DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE
2.7.3. TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. TECHNOLOGICAL ADVANCEMENTS
3.1.2. PREVALENCE OF CANCER AND CVD ACROSS THE GLOBE
3.1.3. GROWING ADOPTION AMONG HOSPITALS
3.1.4. GROWING FOCUS AMONG HEALTHCARE ORGANIZATIONS TO INCREASE WORKFLOW EFFICIENCY
3.2. MARKET RESTRAINTS
3.2.1. TECHNICAL COMPLEXITIES
3.2.2. HIGH COST OF AV TOOLS
3.3. MARKET OPPORTUNITIES
3.3.1. GROWING MEDICAL TOURISM ACROSS THE GLOBE
3.3.2. INCREASING HEALTHCARE EXPENDITURE IN DEVELOPING COUNTRIES
3.4. MARKET CHALLENGES
3.4.1. HIGH INITIAL INVESTMENT
3.4.2. LACK OF SKILLED PROFESSIONALS
4. MARKET SEGMENTATION
4.1. GLOBAL ADVANCED VISUALIZATION MARKET BY TYPE OF PLATFORM 2014-2023 ($ MILLION)
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION BY TYPE OF PLATFORM 2014-2023 ($ MILLION)
4.1.5.1. GLOBAL ADVANCED VISUALIZATION MARKET BY COMPUTED TOMOGRAPHY (CT) 2014-2023 ($ MILLION)
4.1.5.1.1. APPLICATION
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.1.6. KEY CONCLUSIONS
4.1.5.2. GLOBAL ADVANCED VISUALIZATION MARKET BY ULTRASOUND 2014-2023 ($ MILLION)
4.1.5.2.1. APPLICATION
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.2.6. KEY CONCLUSIONS
4.1.5.3. GLOBAL ADVANCED VISUALIZATION MARKET BY POSITRON EMISSION TOMOGRAPHY (PET) 2014-2023 ($ MILLION)
4.1.5.3.1. APPLICATION
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.3.6. KEY CONCLUSIONS
4.1.5.4. GLOBAL ADVANCED VISUALIZATION MARKET BY RADIOTHERAPY (RT) 2014-2023 ($ MILLION)
4.1.5.4.1. APPLICATION
4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.4.6. KEY CONCLUSIONS
4.1.5.5. GLOBAL ADVANCED VISUALIZATION MARKET BY MAGNETIC RESONANCE IMAGING (MRI) 2014-2023 ($ MILLION)
4.1.5.6. APPLICATION
4.1.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.6.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.6.4. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.6.5. KEY CONCLUSIONS
4.1.5.7. GLOBAL ADVANCED VISUALIZATION MARKET BY OTHERS 2014-2023 ($ MILLION)
4.1.5.7.1. APPLICATION
4.1.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.7.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.7.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.1.5.7.6. KEY CONCLUSIONS
4.2. GLOBAL ADVANCED VISUALIZATION MARKET BY APPLICATION 2014-2023 ($ MILLION)
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION BY APPLICATION 2014-2023 ($ MILLION)
4.2.5.1. GLOBAL ADVANCED VISUALIZATION MARKET BY NEUROLOGY 2014-2023 ($ MILLION)
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.2.5.1.6. KEY CONCLUSIONS
4.2.5.2. GLOBAL ADVANCED VISUALIZATION MARKET BY ONCOLOGY 2014-2023 ($ MILLION)
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.2.5.2.6. KEY CONCLUSIONS
4.2.5.3. GLOBAL ADVANCED VISUALIZATION MARKET BY CARDIOLOGY 2014-2023 ($ MILLION)
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.2.5.3.6. KEY CONCLUSIONS
4.2.5.4. GLOBAL ADVANCED VISUALIZATION MARKET BY ORTHOPEDICS 2014-2023 ($ MILLION)
4.2.5.4.1. APPLICATION
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.2.5.4.6. KEY CONCLUSIONS
4.2.5.5. GLOBAL ADVANCED VISUALIZATION MARKET BY OTHER APPLICATIONS 2014-2023 ($ MILLION)
4.2.5.6. APPLICATION
4.2.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.6.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.6.4. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.2.5.6.5. KEY CONCLUSIONS
4.3. GLOBAL ADVANCED VISUALIZATION MARKET BY END USER 2014-2023 ($ MILLION)
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION BY END USER 2014-2023 ($ MILLION)
4.3.5.1. GLOBAL ADVANCED VISUALIZATION MARKET BY ACADEMIC & RESEARCH CENTERS 2014-2023 ($ MILLION
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.5.1.6. KEY CONCLUSIONS
4.3.5.2. GLOBAL ADVANCED VISUALIZATION MARKET BY IMAGING CENTERS 2014-2023 ($ MILLION)
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.5.2.6. KEY CONCLUSIONS
4.3.5.3. GLOBAL ADVANCED VISUALIZATION MARKET BY HOSPITALS & SURGICAL CENTERS 2014-2023 ($ MILLION)
4.3.5.3.1. APPLICATION
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.5.3.6. KEY CONCLUSIONS
4.3.5.4. GLOBAL ADVANCED VISUALIZATION MARKET BY OTHER END USERS 2014-2023 ($ MILLION)
4.3.5.4.1. APPLICATION
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5. REGIONAL ANALYSIS 2014-2023 ($ MILLION)
4.3.5.4.6. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF M&A
5.1.2. LIST OF JV
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL ADVANCED VISUALIZATION MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRIAL APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. CARESTREAM HEALTH INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. CONMED CORPORATION
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. FUJIFILM HOLDINGS CORPORATION
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. GE HEALTHCARE
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. HITACHI
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. MCKESSON CORPORATION
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. NOVARAD
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. PHILIPS NV
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. PRO MEDICUS
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. QI IMAGING
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. RAMSOFT
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. SIEMENS AG
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.13. TERARECON INC.
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. TOSHIBA CORPORATION
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. VITAL IMAGES
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL ADVANCED VISUALIZATION MARKET BY TYPE OF PLATFORM ($ MILLION)
GLOBAL COMPUTED TOMOGRAPHY ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL ULTRASOUND ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL RADIOTHERAPY (RT) ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL MAGNETIC RESONANCE IMAGING (MRI) ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL OTHERS ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY APPLICATION ($ MILLION)
GLOBAL NEUROLOGY ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL ONCOLOGY ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL CARDIOLOGY ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL ORTHOPEDICS ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL OTHER ADVANCED VISUALIZATION APPLICATIONS BY GEOGRAPHY ($ MILLION)
GLOBAL ADVANCED VISUALIZATION BY END USER ($ MILLION)
GLOBAL ACADEMIC & RESEARCH CENTERS ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL IMAGING CENTERS ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL HOSPITALS & SURGICAL CENTERS ADVANCED VISUALIZATION BY GEOGRAPHY ($ MILLION)
GLOBAL OTHER ADVANCED VISUALIZATION END USERS BY GEOGRAPHY ($ MILLION)
NORTH AMERICA ADVANCED VISUALIZATION MARKET ($ MILLION)
EUROPE ADVANCED VISUALIZATION MARKET ($ MILLION)
ASIA PACIFIC ADVANCED VISUALIZATION MARKET ($ MILLION)
REST OF THE WORLD ADVANCED VISUALIZATION MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL ADVANCED VISUALIZATION MARKET BY COMPUTED TOMOGRAPHY ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY ULTRASOUND ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY POSITRON EMISSION TOMOGRAPHY (PET) ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY RADIOTHERAPY (RT) ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY MAGNETIC RESONANCE IMAGING (MRI) ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY OTHERS ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY NEUROLOGY ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY ONCOLOGY ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY CARDIOLOGY ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY ORTHOPEDICS ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY OTHER APPLICATIONS ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY ACADEMIC & RESEARCH CENTERS ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY IMAGING CENTERS ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY HOSPITALS & SURGICAL CENTERS ($ MILLION)
GLOBAL ADVANCED VISUALIZATION MARKET BY OTHER END USERS ($ MILLION)
UNITED STATES (U.S.) ADVANCED VISUALIZATION MARKET ($ MILLION)
CANADA ADVANCED VISUALIZATION MARKET ($ MILLION)
UNITED KINGDOM (UK) ADVANCED VISUALIZATION MARKET ($ MILLION)
FRANCE ADVANCED VISUALIZATION MARKET ($ MILLION)
GERMANY ADVANCED VISUALIZATION MARKET ($ MILLION)
SPAIN ADVANCED VISUALIZATION MARKET ($ MILLION)
ITALY ADVANCED VISUALIZATION MARKET ($ MILLION)
ROE ADVANCED VISUALIZATION MARKET ($ MILLION)
INDIA ADVANCED VISUALIZATION MARKET ($ MILLION)
CHINA ADVANCED VISUALIZATION MARKET ($ MILLION)
JAPAN ADVANCED VISUALIZATION MARKET ($ MILLION)
KOREA ADVANCED VISUALIZATION MARKET ($ MILLION)
AUSTRALIA ADVANCED VISUALIZATION MARKET ($ MILLION)
ROAPAC ADVANCED VISUALIZATION MARKET ($ MILLION)
LATIN AMERICA ADVANCED VISUALIZATION MARKET ($ MILLION)
MENA ADVANCED VISUALIZATION MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report